Cargando…
"Ejaculatory disorders and α(1)-adrenoceptor antagonists therapy: clinical and experimental researches"
BACKGROUND: It is well known that the use of the α-adrenergic receptor antagonists in the BPH therapy may induce ejaculatory disorder. A review of clinical literature shows a greater incidence of ejaculatory disorder during the use of tamsulosin compared with alfuzosin. Anejaculation has been until...
Autores principales: | Grasso, Marco, Fortuna, Flavio, Lania, Caterina, Blanco, Salvatore |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1550429/ https://www.ncbi.nlm.nih.gov/pubmed/16842616 http://dx.doi.org/10.1186/1479-5876-4-31 |
Ejemplares similares
-
Preservation of Cavernosal Erectile Function after Soft Penile Prosthesis Implant in Peyronie's Disease: Long-Term Followup
por: Grasso, Marco, et al.
Publicado: (2008) -
Reduction in PSA messenger-RNA expression and clinical recurrence in patients with prostatic cancer undergoing neoadjuvant therapy before radical prostatectomy
por: Grasso, Marco, et al.
Publicado: (2004) -
The office management of ejaculatory disorders
por: Jiann, Bang-Ping
Publicado: (2016) -
The affinity and selectivity of α‐adrenoceptor antagonists, antidepressants and antipsychotics for the human α2A, α2B, and α2C‐adrenoceptors and comparison with human α1 and β‐adrenoceptors
por: Proudman, Richard G.W., et al.
Publicado: (2022) -
Repurposing of α1-Adrenoceptor Antagonists: Impact in Renal Cancer
por: Mihalopoulos, Meredith, et al.
Publicado: (2020)